VIATRIS INC. Income Taxes Paid
VIATRIS INC. (VTRS) reported Income Taxes Paid of $514.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2026-02-26
- VIATRIS INC. income taxes paid for the quarter ending 2020-12-31 was $324.40M.
- VIATRIS INC. income taxes paid for the quarter ending 2020-09-27 was $0.00.
- VIATRIS INC. income taxes paid for the quarter ending 2020-06-28 was $0.00.
- VIATRIS INC. income taxes paid for the quarter ending 2020-03-29 was $0.00.
- VIATRIS INC. income taxes paid for fiscal 2024 was $514.00M, a 9.97% decline from fiscal 2023.
- VIATRIS INC. income taxes paid for fiscal 2023 was $570.90M, a 22.35% decline from fiscal 2022.
- VIATRIS INC. income taxes paid for fiscal 2022 was $735.20M, a 14.57% increase from fiscal 2021.
- VIATRIS INC. income taxes paid for fiscal 2021 was $641.70M, a 97.81% increase from fiscal 2020.
| Period end | Income Taxes Paid 1 month | Income Taxes Paid 3 month | Income Taxes Paid 4 month | Income Taxes Paid 6 month | Income Taxes Paid 7 month | Income Taxes Paid 9 month | Income Taxes Paid 11 month | Income Taxes Paid 12 month |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $514.00M 10-K · filed 2026-02-26 | |||||||
| 2023-12-31 | $570.90M 10-K · filed 2026-02-26 | |||||||
| 2022-12-31 | $735.20M 10-K · filed 2025-02-27 | |||||||
| 2021-12-31 | $641.70M 10-K · filed 2024-02-28 | |||||||
| 2020-12-31 | $324.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $324.40M derived: sum of 2 quarters · filed 2023-02-27 | $324.40M derived: sum of 3 quarters · filed 2023-02-27 | $324.40M 10-K · filed 2023-02-27 | ||||
| 2020-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $0.00 derived: sum of 2 quarters · filed 2020-11-10 | $0.00 10-Q · filed 2020-11-10 | |||||
| 2020-06-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $0.00 10-Q · filed 2020-08-12 | ||||||
| 2020-03-29 | $0.00 10-Q · filed 2020-05-12 | |||||||
| 2019-12-31 | $0.00 10-K · filed 2020-05-07 | $278.60M 10-K · filed 2022-02-28 | ||||||
| 2019-09-29 | $0.00 10-Q · filed 2020-11-10 | |||||||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-12 | |||||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-12 | |||||||
| 2018-12-31 | $228.60M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |